Co-expression of the β2-adrenoceptor and dopamine D1-receptor with Gsα proteins in Sf9 insect cells: Limitations in comparison with fusion proteins

Biochimica et Biophysica Acta - Biomembranes

Volumn 1613, Issue 1-2, 2003, Pages 101-114

  Gille, Andreas ^a   Seifert, Roland ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

Adenylyl cyclase; Dopamine D1 receptor; Gs splice variant; G olf; Sf9 insect cell; 2 adrenoceptor

Indexed keywords

ADENYLATE CYCLASE; BETA 2 ADRENERGIC RECEPTOR; DOPAMINE 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; HYBRID PROTEIN; ISOPROTEIN; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIHYDROALPRENOLOL; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ARTICLE; COMPARATIVE STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; INSECT CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR BINDING; ALTERNATIVE RNA SPLICING; ANIMAL; ARMYWORM; BINDING SITE; CELL LINE; GENETIC TRANSFECTION; GENETIC VARIABILITY; GENETICS; METABOLISM; RAT;

INSECTA;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ALTERNATIVE SPLICING; ANIMALS; BINDING SITES; CELL LINE; DIHYDROALPRENOLOL; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); RATS; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, DOPAMINE D1; RECOMBINANT FUSION PROTEINS; SPODOPTERA; TRANSFECTION; VARIATION (GENETICS);

EID: 0041733487     PISSN: 00052736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0005-2736(03)00174-3     Document Type: Article

References (71)

1. Gilman A.G. G proteins: transducers of receptor-generated signals. Ann. Rev. Biochem. 56:1987;615-649.
2. Birnbaumer L., Abramowitz J., Brown A.M. Receptor-effector coupling by G proteins. Biochim. Biophys. Acta. 1031:1990;163-224.
3. Gudermann T., Kalkbrenner F., Schultz G. Diversity and selectivity of receptor-G protein interaction. Annu. Rev. Pharmacol. Toxicol. 36:1996;429-459.
4. Sternweis P.C., Northup J.K., Smigel M.D., Gilman A.G. The regulatory component of adenylate cyclase. Purification and properties. J. Biol. Chem. 256:1981;11517-11526.
5. Robishaw J.D., Smigel M.D., Gilman A.G. Molecular basis for two forms of the G protein that stimulates adenylate cyclase. J. Biol. Chem. 261:1986;9587-9590.
6. αs signal transduction protein. Proc. Natl. Acad. Sci. U. S. A. 83:1986;8893-8897.
7. Jones D.T., Reed R.R. Molecular cloning of five GTP-binding protein cDNA species from rat olfactory neuroepithelium. J. Biol. Chem. 262:1987;14241-14249.
8. olf: an olfactory neuron specific-G protein involved in odorant signal transduction. Science. 244:1989;790-795.
9. Mumby S.M., Kahn R.A., Manning D.R., Gilman A.G. Antisera of designed specificity for subunits of guanine nucleotide-binding regulatory proteins. Proc. Natl. Acad. Sci. U. S. A. 83:1986;265-269.
10. Chaudhry A., Granneman J.G. Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat. Am. J. Physiol. 261:1991;R403-R411.
11. Kawai Y., Arinze I.J. Ontogeny of guanine-nucleotide-binding regulatory proteins in rabbit liver. Biochem. J. 274:1991;439-444.
12. Kawai Y., Arinze I.J. Differential localization and development-dependent expression of G-protein subunits, Goα and Gβ, in rabbit heart. J. Mol. Cell. Cardiol. 28:1996;1555-1564.
13. olf α: complementary deoxyribonucleic acid structure and expression in pancreatic islets and other tissues outside the olfactory neuroepithelium and central nervous system. Endocrinology. 133:1993;2508-2514.
14. sα protein mRNA in rat ventricular myocardium with aging. Eur. J. Pharmacol. 266:1994;147-154.
15. olf α and adenylyl cyclase mRNA expressions in the rat heart during ontogenic development. J. Mol. Cell. Cardiol. 31:1999;1137-1142.
16. s-α in neostriatum and cerebellum: correlation with expression of calmodulin-independent adenylyl cyclase. Brain Res. 523:1990;143-146.
17. olf proteins and adenylyl cyclases in mouse brain membranes. Brain Res. 643:1994;50-58.
18. Morishita R., Shinohara H., Ueda H., Kato K., Asano T. High expression of the γ5 isoform of G protein in neuroepithelial cells and its replacement of the γ2 isoform during neuronal differentiation in the rat brain. J. Neurochem. 73:1999;2369-2374.
19. sα. J. Neurochem. 79:2001;88-97.
20. αolf identification by RT-PCR in purified normal pancreatic B cells and in islets from rat models of non-insulin-dependent diabetes. Biochem. Biophys. Res. Commun. 254:1999;269-272.
21. i in adipocyte plasma membranes of genetically diabetic (db/db) mice. Am. J. Physiol. 263:1992;C121-C129.
22. Ozawa H., Katamura Y., Hatta S., Saito T., Katada T., Gsell W., Froelich L., Takahata N., Riederer P. Alterations of guanine nucleotide-binding proteins in post-mortem human brain in alcoholics. Brain Res. 620:1993;174-179.
23. Cowburn R.F., Marcusson J.O., Eriksson A., Wiehager B., O'Neill C. Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res. 633:1994;297-304.
24. Penit-Soria J., Durand C., Besson M.J., Hervé D. Levels of stimulatory G protein are increased in the rat striatum after neonatal lesion of dopamine neurons. NeuroReport. 8:1997;829-833.
25. 1 receptor with adenylyl cyclase. J. Neurosci. 13:1993;2237-2248.
26. olf are anosmic. Neuron. 20:1998;69-81.
27. sα in Escherichia coli. Purification and properties of two forms of the protein. J. Biol. Chem. 264:1989;409-418.
28. olf. J. Biol. Chem. 265:1990;2671-2676.
29. - cells. Mol. Pharmacol. 39:1991;702-710.
30. s has greater functional activity than the 52-kDa α-subunit. J. Biol. Chem. 264:1989;21106-21111.
31. α fusion proteins: an approach for the molecular analysis of receptor/G-protein coupling. Trends Pharmacol. Sci. 20:1999;383-389.
32. Milligan G. Insights into ligand pharmacology using receptor-G-protein fusion proteins. Trends Pharmacol. Sci. 21:2000;24-28.
33. Molinari P., Ambrosio C., Riitano D., Sbraccia M., Grò M.C., Costa T. Promiscuous coupling at receptor-Gα fusion proteins. The receptor of one covalent complex interacts with the α-subunit of another. J. Biol. Chem. 278:2003;15778-15788.
34. sα has properties of a constitutively active receptor. J. Biol. Chem. 273:1998;5109-5116.
35. 3. J. Biol. Chem. 274:1999;33259-33266.
36. q-proteins. Mol. Pharmacol. 58:2000;954-966.
37. sαshort: consequences for receptor-coupling and adenylyl cyclase activation. J. Neurochem. 78:2001;325-338.
38. sα splice variants. J. Pharmacol. Exp. Ther. 298:2001;840-847.
39. sα splice variants. Biochem. Pharmacol. 64:2002;9-20.
40. sα. J. Pharmacol. Exp. Ther. 299:2001;1013-1020.
41. 2a receptors to adenylyl cyclase in the striatum. J. Neurochem. 76:2001;1585-1588.
42. 2 adrenergic receptor. Evidence for ligand-specific conformational changes. J. Biol. Chem. 270:1995;28268-28275.
43. sα fusion protein. Eur. J. Biochem. 255:1998;369-382.
44. Alvarez R., Daniels D.V. A single column method for the assay of adenylate cyclase. Anal. Biochem. 187:1990;98-103.
45. s. Naunyn-Schmiedeberg's Arch. Pharmacol. 365:2002;231-241.
46. 1-like dopamine receptor. J. Neurochem. 45:1985;1601-1611.
47. De Lean A., Stadel J.M., Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled β-adrenergic receptor. J. Biol. Chem. 255:1980;7108-7117.
48. Kenakin T. The classification of seven transmembrane receptors in recombinant expression systems. Pharmacol. Rev. 48:1996;413-463.
49. Gierschik P., Moghtader R., Straub C., Dieterich K., Jakobs K.H. Signal amplification in HL-60 granulocytes. Evidence that the chemotactic peptide receptor catalytically activates guanine-nucleotide-binding regulatory proteins in native plasma membranes. Eur. J. Biochem. 197:1991;725-732.
50. Wenzel-Seifert K., Hurt C.M., Seifert R. High constitutive activity of the human formyl peptide receptor. J. Biol. Chem. 273:1998;24181-24189.
51. Parker E.M., Kameyama K., Higashijima T., Ross E.M. Reconstitutively active G protein-coupled receptors purified from baculovirus-infected insect cells. J. Biol. Chem. 266:1991;519-527.
52. 2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J. Biol. Chem. 271:1996;16384-16392.
53. Richardson R.M., Hosey M.M. Agonist-induced phosphorylation and desensitization of human m2 muscarinic cholinergic receptors in Sf9 insect cells. J. Biol. Chem. 267:1992;22249-22255.
54. sα with the cytosolic domains of mammalian adenylyl cyclase. J. Biol. Chem. 272:1997;22265-22271.
55. Lefkowitz R.J., Cotecchia S., Samama P., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:1993;303-307.
56. Seifert R., Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 366:2002;381-416.
57. 2-adrenergic receptor. Extending the ternary complex model. J. Biol. Chem. 268:1993;4625-4636.
58. Chidiac P., Hebert T.E., Valiquette M., Dennis M., Bouvier M. Inverse agonist activity of β-adrenergic antagonists. Mol. Pharmacol. 45:1994;490-499.
59. s interactions: evidence for multiple receptor conformations. Mol. Pharmacol. 56:1999;348-358.
60. s protein. Mol. Pharmacol. 56:1999;989-996.
61. 2-adrenergic receptor. Mol. Pharmacol. 45:1994;390-394.
62. sα reduces its GDP/GTP exchange rate. J. Cell. Biochem. 76:2000;368-375.
63. o: assay using recombinant a subunits in reconstituted phospholipid vesicles. Biochemistry. 30:1991;10769-10777.
64. Freissmuth M., Selzer E., Marullo S., Schütz W., Strosberg A.D. Expression of two human β-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein. Proc. Natl. Acad. Sci. U. S. A. 88:1991;8548-8552.
65. Neubig R.R. Membrane organization in G-protein mechanisms. FASEB J. 8:1994;939-946.
66. Steinberg S.F., Brunton L.L. Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu. Rev. Pharmacol. Toxicol. 41:2001;751-773.
67. s. J. Pharmacol. Exp. Ther. 294:2000;407-412.
68. Yagami T. Differential coupling of glucagon and β-adrenergic receptors with the small and large forms of the stimulatory G protein. Mol. Pharmacol. 48:1995;849-854.
69. 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc. Natl. Acad. Sci. U. S. A. 97:2000;3684-3689.
70. Kvapil P., Novotny J., Svoboda P., Ransnäs L.A. The short and long forms of the a subunit of the stimulatory guanine-nucleotide-binding protein are unequally redistributed during (-)-isoproterenol-mediated desensitization of intact S49 lymphoma cells. Eur. J. Biochem. 226:1994;193-199.
71. Witte K., Schnecko A., Lemmer B. Agonist-induced release of splice variants of the α subunit of the stimulatory G-protein from rat cardiac membranes. Biochem. Pharmacol. 57:1999;539-543.